{"id":"W4410822512","doi":"10.1200/jco.2025.43.16_suppl.tps3171","title":"A first-in-human multi-center phase 1/2 study of a selective FGFR2/3 inhibitor, CGT4859, in patients with intrahepatic cholangiocarcinomas or other advanced solid tumors.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network","funders":"Unum Therapeutics","keywords":"Medicine; Solid tumor; Intrahepatic Cholangiocarcinoma; Oncology; Internal medicine; Cancer research; Radiology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001750579,0.00224453,0.002629616,0.0005626547,0.0006161509,0.001431667,0.001188179,0.002032046,0.006251397],"category_scores_gemma":[0.0008351667,0.0008477318,0.002075699,0.0004975859,0.0008878916,0.001183652,0.0005202754,0.003392824,0.001877907],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001260119,"about_ca_system_score_gemma":0.002229127,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002175376,"about_ca_topic_score_gemma":0.006419349,"domain_scores_codex":[0.9995116,0.0001713139,0.0000217976,0.0001043471,0.00005026899,0.0001407093],"domain_scores_gemma":[0.9992704,0.00006317205,0.0001111272,0.00006410888,0.00007274665,0.0004184601],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5176814,0.1162578,0.007948039,0.002661384,0.003681105,0.001110925,0.0006234102,0.005837067,0.1366242,0.0006180116,0.01957995,0.1873767],"study_design_scores_gemma":[0.4406416,0.5249259,0.01192684,0.00008979861,0.001137729,0.001076616,0.0001441003,0.001777586,0.008195395,0.0004235425,0.009593534,0.00006735939],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9634576,0.007599928,0.004083654,0.001625342,0.0004923436,0.01115124,0.005862255,0.0005825792,0.005144971],"genre_scores_gemma":[0.9639546,0.005275802,0.006100807,0.002771698,0.0002734252,0.00788739,0.006769294,0.0001866852,0.006780272],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006251397,"threshold_uncertainty_score":0.020913,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04407917643325134,"score_gpt":0.4446313771914444,"score_spread":0.4005522007581931,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}